PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

PAR2 promotes tumor-associated angiogenesis in lung adenocarcinoma through activating EGFR pathway

Published:2022-12 Issue: Volume:79 Page:101918
ISSN:0040-8166
Container-title:Tissue and Cell
language:en
Short-container-title:Tissue and Cell

Author:

Li Yong,Huang Huiqin,Chen Xiaoyun,Yu Nanding,Ye Xiangli,Chen Limin,Huang Zhenghui

Funder

Natural Science Foundation of Fujian Province

Fujian Provincial Health Technology Project

Publisher

Elsevier BV

Subject

Cell Biology,Developmental Biology,General Medicine

Reference37 articles.

1. Editorial: update on the biology, management, and treatment of small cell lung cancer;Puri;Front Oncol.,2020

2. The role of microenvironment in tumor angiogenesis;Jiang;J. Exp. Clin. Cancer Res.,2020

3. Angiogenesis in pancreatic cancer: current research status and clinical implications;Li;Angiogenesis,2019

4. Tumor angiogenesis and vascular normalization: alternative therapeutic targets;Viallard;Angiogenesis,2017

5. PRMT1-mediated H4R3me2a recruits SMARCA4 to promote colorectal cancer progression by enhancing EGFR signaling;Yao;Genome Med.,2021

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Myeloid cell differentiation-related gene signature for predicting clinical outcome, immune microenvironment, and treatment response in lung adenocarcinoma;Scientific Reports;2024-07-29

2. A Novel Nucleic Acid Sensing-related Genes Signature for Predicting Immunotherapy Efficacy and Prognosis of Lung Adenocarcinoma;Current Cancer Drug Targets;2024-04

3. Identification of a Novel Prognostic Lymphangiogenesis-Related Signature Associated with Tumor Immunity for Guiding Therapy in Lung Adenocarcinoma;Analytical Cellular Pathology;2024-02-17

4. Upamostat: a serine protease inhibitor for antiviral, gastrointestinal, and anticancer indications;Expert Opinion on Investigational Drugs;2023-11-23

5. Protease-activated receptor 2 attenuates doxorubicin-induced apoptosis in colon cancer cells;Journal of Cell Communication and Signaling;2023-11-22

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3